Paradoxically, NRF2 has also been shown to promote or exacerbate pathophysiological cardiovascular outcomes under different scenarios and appears to have a dual function in disorders such as atherosclerosis, obesity and T2DM, as reviewed in more detail here [86]. The gene discussed is NFE2L2; the disease is atherosclerosis.